---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-25-000101"
form_type: "8-K/A"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:36:06.213594+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AtriCure Q3 revenue $134.3M (+15.8% YoY); net loss narrows to $0.3M; raises FY2025 outlook

## Summary
- Revenue $134.3M, +15.8% YoY (+15.1% constant currency); US $109.3M (+14.5%), intl $25.0M (+22.0%).
- Net loss $0.3M vs $7.9M loss in Q3 2024; GAAP EPS loss $0.01 vs $0.17; adjusted EBITDA $17.8M (+$9.9M).
- Generated $30.1M cash in Q3, $25.1M YTD; raised full-year 2025 financial outlook.
- Key product drivers: AtriClip FLEX-Mini, EnCompass clamp, cryoSPHERE MAX probe for pain management.
- Gross margin 75.5%, up 59 bps YoY on favorable product mix.

## SEC filing metadata
- accession: 0001323885-25-000101
- form_type: 8-K/A
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000101/0001323885-25-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000101/atrc-20251029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-25-000101
- JSON: https://secwatch.observer/filing/0001323885-25-000101.json
- Plain text: https://secwatch.observer/filing/0001323885-25-000101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.